Impact of Histologic Variants of Bladder Cancer on Oncology Outcome After Radical Cystectomy

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the oncological outcome of histologic variants in bladder cancer patients who underwent radical cystectomy. Materials and Methods: We identified 393 bladder cancer patients who underwent radical cystectomy at single center between January 2007 and August 2014. Patients were divided into 4 groups according to histologic types: pure urothelial cell carcinoma (UC) and squamous, micropapillary, and other variants. Kaplan-Meier analysis was performed to assess recurrence-free (RFS) and overall survivals (OS). The patients were divided into those with pathologic stage and nodal status. Results: Among 393 bladder cancer patients, squamous, micropapillary histologic variants were observed in 38 (9.7%), 26 (6.6%), respectively, whereas 39 had other variant types. Stage T3 cancer occurred in more patients with histologic variant compared with those with pure UC. Pathologic positive nodal status was also frequently found in the histologic variant groups. Subgroup analysis according to T stage and nodal status showed no significant difference in RFS and OS. On multivariate analysis, pathologic T stage (stage T2: hazard ratio [HR], 2.75; 95% confidence interval [CI], 1.34–5.63; p=0.005; stage ≥T3: HR, 3.20; 95% CI, 1.62–6.30; p=0.001) and nodal status (HR, 1.85; 95% CI, 1.05–2.56; p=0.028) were prognostic factors for RFS. Conclusions: In patients who underwent radical cystectomy, histologic variants were detected more often at advanced pathologic stage. Although histologic variants have been identified in the radical cystectomy specimen, treatment should be performed according to the pathologic stage.

참고문헌 (Reference)

1 Shah RB, "Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital" 31 : 1650-1655, 2013

2 Yasui M, "Urinary bladder carcinoma with divergent differentiation featuring small cell carcinoma, sarcomatoid carcinoma, and liposarcomatous component" 212 : 833-837, 2016

3 Abd El-Latif A, "The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy" 189 : 1263-1267, 2013

4 Antunes AA, "The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy" 33 : 339-345, 2007

5 Kamat AM, "The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma" 175 (175): 881-885, 2006

6 Prudnick C Morley C, "Squamous cell carcinoma of the bladder mimicking interstitial cystitis and voiding dysfunction" 2013 : 924918-, 2013

7 Bertz S, "Specific types of bladder cancer" 37 : 40-51, 2016

8 Stein JP, "Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients" 19 : 666-675, 2001

9 Freeman JA, "Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction" 76 : 833-839, 1995

10 Dayyani F, "Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis" 189 : 1656-1661, 2013

11 Qin Q, "Obesity and risk of bladder cancer: a meta-analysis of cohort studies" 14 : 3117-3121, 2013

12 Sun JW, "Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies" 10 : e0119313-, 2015

13 Grossman HB, "Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer" 349 : 859-866, 2003

14 Kamat AM, "Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients" 110 : 62-67, 2007

15 Masson-Lecomte A, "Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma" 32 : 531-537, 2014

16 Kim HS, "Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder" 5 : 9626-, 2015

17 Chalasani V, "Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer" 3 (3): S193-S198, 2009

18 Mitra AP, "Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis" 32 : 117-127, 2014

19 Monn MF, "Contemporary bladder cancer: variant histology may be a significant driver of disease" 33 : 18.e15-18.e20, 2015

20 Gluck G, "Comparative study of conventional urothelial carcinoma, squamous differentiation carcinoma and pure squamous carcinoma in patients with invasive bladder tumors" 7 : 211-214, 2014

21 Krasnow RE, "Clinical outcomes of patients with histologic variants of urothelial cancer treated with trimodality bladder-sparing therapy" 72 : 54-60, 2017

22 Kamat AM, "Bladder cancer" 388 : 2796-2810, 2016

23 Kukreja JB, "Advances in surgical management of muscle invasive bladder cancer" 33 : 106-110, 2017

24 Alvarado-Cabrero I, "A clinicopathologic study of 38 cases" 9 : 1-5, 2005